DEUTSCHE BANK AG\ - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 17 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$3,0001,961
+880.5%
0.00%
Q3 2019$0
-100.0%
200
-89.5%
0.00%
Q2 2019$2,000
-90.5%
1,900
-83.5%
0.00%
Q1 2019$21,000
-81.6%
11,500
-75.4%
0.00%
Q2 2018$114,000
-85.2%
46,800
-21.8%
0.00%
Q1 2018$771,000
+81.8%
59,837
+56.3%
0.00%
Q4 2017$424,000
-8.8%
38,291
+3.3%
0.00%
Q3 2017$465,000
+474.1%
37,072
+419.1%
0.00%
Q2 2017$81,000
+20.9%
7,142
+37.9%
0.00%
Q1 2017$67,000
+123.3%
5,178
+43.4%
0.00%
Q4 2016$30,000
-44.4%
3,610
-40.3%
0.00%
Q3 2016$54,000
+22.7%
6,049
+6.1%
0.00%
Q2 2016$44,0005,7000.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
Granite Point Capital Management, L.P. 127,841$1,331,0000.91%
SPHERA FUNDS MANAGEMENT LTD. 205,200$2,136,0000.27%
LANSDOWNE PARTNERS (UK) LLP 930,000$9,681,0000.08%
Point72 Asset Management, L.P. 919,639$9,573,0000.08%
EverPoint Asset Management, LLC 100,000$1,041,0000.03%
AXA S.A. 376,205$3,916,0000.02%
First Eagle Investment Management, LLC 175,000$1,822,0000.01%
Tower Research Capital LLC (TRC) 1,228$13,0000.00%
UBS Group AG 880$9,0000.00%
WELLS FARGO & COMPANY/MN 2,500$26,0000.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders